Clinical Trial

PulseMagic™ TrueForce™ PAF NMPA Study

NCT: NCT07720557 · NOT_YET_RECRUITING

NCT IDNCT07720557

StatusNOT_YET_RECRUITING

Start Date2026-07-10

Completion2028-11-30

SponsorShanghai MicroPort EP MedTech Co., Ltd. (INDUSTRY)

First posted2026-07-22

Last updated2026-07-22

Brief Summary

This clinical investigation is intended to demonstrate safety and effectiveness of the PulseMagic™ TrueForce™ Ablation Catheter and the PulseMagic™Pulse Field Ablation (PFA) Generator, and Columbus™ 3D EP Navigation System with Pulsed Field Ablation Software for the treatment of symptomatic, recurrent, drug refractory paroxysmal atrial fibrillation (PAF).

Frequently Asked Questions

What is PulseMagic™ TrueForce™ PAF NMPA Study?

PulseMagic™ TrueForce™ PAF NMPA Study is a clinical trial registered under NCT07720557. Current status: NOT_YET_RECRUITING.

What is the status of NCT07720557?

The current status of NCT07720557 (PulseMagic™ TrueForce™ PAF NMPA Study) is: NOT_YET_RECRUITING.

When did PulseMagic™ TrueForce™ PAF NMPA Study start?

PulseMagic™ TrueForce™ PAF NMPA Study started on 2026-07-10.

Related Devices

K210313EasyFinder Fixed Curve Diagnostic Catheter, Forlnk Cable for Mapping CatheterShanghai Microport EP Medtech Co., Ltd. K211530PathBuilder Steerable IntroducerShanghai Microport EP Medtech Co., Ltd. K212625PathBuilder Transseptal NeedleShanghai Microport EP Medtech Co., Ltd. K212626PathBuilder Transseptal Guiding IntroducerShanghai Microport EP Medtech Co., Ltd. K223094EnSite™ X EP System TactiFlex™ Ablation Catheter, Sensor Enabled™, Software Upgrade; EnSite™ X EP System TactiFlex™ Ablation Catheter, Sensor Enabled™, Software LicenseABBOTT MEDICAL

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.